Phlow

Phlow is a mission-driven pharmaceutical manufacturer established to address vulnerabilities in the U.S. supply chain for essential generic medicines and APIs. The company leverages advanced manufacturing technologies, including continuous flow manufacturing, to produce high-quality, cost-effective generic drugs with a focus on infectious disease treatments and national health security. Backed by significant government contracts and private investment, Phlow aims to create a resilient, end-to-end domestic manufacturing ecosystem for critical pharmaceuticals, positioning itself as a key player in reshoring pharmaceutical production.

Advanced pharmaceutical manufacturing platform integrating continuous flow manufacturing (CFM) for API synthesis and finished dosage form production, aimed at creating a resilient, domestic supply chain for essential generic medicines.

Phlow operates in a nascent but growing field of domestic advanced pharmaceutical manufacturing. Direct competitors include established CDMOs investing in continuous manufacturing and new ventures focused on supply chain resilience. Its primary competition, however, is the entrenched overseas generic manufacturing base in Asia, which competes on cost but is increasingly scrutinized for reliability and quality.